NUCLEOLIN and hepatocellular carcinoma: Our study has further demonstrated the anti-tumor efficacy of NCL inactivation via knockdown and antibodies neutralization in suppressing the tumorigenicity of hepatoma cells even in the presence of excessive HDGF.